Results for:(135 found)
Nov 7, 2012 12:15PM on Top StocksBy Minyanville.com

The pharma wins US approval for a new rheumatoid arthritis pill, but Abbott's existing treatment isn't likely to suffer a meaningful hit to sales anytime soon.

Nov 2, 2012 12:10PM on Top StocksBy TheStockAdvisors

These undervalued equities offer rapid growth potential and strong finances.

Nov 2, 2012 9:20AM on Top StocksBy Stock Traders Daily

Right now it may be the main thing that's propping up shares of the gene sequencing company.

Oct 24, 2012 10:46AM on Top StocksBy TheStreet Staff

The company raises sales guidance while reporting better-than-expected Q3 earnings.

Oct 18, 2012 11:43AM on Top StocksBy Stock Traders Daily

Although Abbott has recently gained on positive trial results, Gilead Sciences remains in the forefront of the market.

Oct 9, 2012 12:59PM on Top StocksBy Minyanville.com

Analyst predicts it will take time, however, before Qsymia records meaningful revenue.

Oct 2, 2012 10:55AM on Top StocksBy TheStockAdvisors

These solid, dividend-paying stocks are well-suited to a buy-and-hold strategy.

Sep 26, 2012 10:19AM on Top StocksBy TheStockAdvisors

Only a few companies that trade as American Depositary Shares earn S&P's 'buy' rating.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.

Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.

Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.

TOP STOCKS

Get ready for a decline

After Tuesday's rally, expect a big raid no matter the news. That's probably the safest way to play it ahead of the Fed.

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More

SMART SPENDING

Start spreading the news -- and the compost

New York's mayor says a composting program would save millions. It's a great frugal hack for anybody, anywhere. Here's how to get started.

More

SMART TAXES

More